Practice Management News

An analysis of online conversations among health care professionals on social media during September revealed mixed reactions toward newly updated messenger RNA COVID-19 vaccines.

A test developed to detect Cache Valley virus and other similar and uncommon viruses yielded fast and accurate results, which could make testing for these viruses easier in the future, according to a study.

Pfizer announced that the FDA has approved Penbraya, the first and only pentavalent vaccine for coverage against the most common serogroups causing meningococcal disease in people aged 10 to 25 years, according to a company press release.

Nirsevimab, a monoclonal antibody recently approved to prevent respiratory syncytial virus-associated lower respiratory disease in newborns and infants, may protect longer than an RSV season, researchers reported at IDWeek.

BOSTON — The Infectious Diseases Society of America is focused on growing the ID workforce and increasing opportunities for its members, its new president told Healio at IDWeek.

Vaccine mandates played a significant role in boosting influenza vaccination rates during the 2020-2021 influenza season, researchers reported in Pediatrics.

Use of a prepopulated antibiotic order panel resulted in greater adherence to guideline recommendations among physicians who treated outpatients with community-acquired pneumonia, according to a study presented at IDWeek.

BOSTON — The Infectious Diseases Society of America Foundation named Edsel Salvana, MD, DTM&H, FDCP, FIDSA, its sixth IDea Incubator Innovator of the year at IDWeek for portable HIV drug resistance testing.

Antibiotic stewardship efforts are likely responsible for a substantial decline in antibiotic use in neonatal ICUs, researchers reported in JAMA Pediatrics.

BOSTON — Aztreonam-avibactam was shown to be effective in the treatment of hospitalized adults who were critically ill with multidrug-resistant, gram-negative bacterial infections, according to the results of the phase 3 REVISIT trial.